Published in Neurology on March 01, 1995
The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U S A (2008) 2.30
Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.80
Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci U S A (1997) 1.36
Brain aging, Alzheimer's disease, and mitochondria. Biochim Biophys Acta (2011) 1.36
The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol (2009) 1.36
Pathogenesis of Alzheimer's disease. Clin Interv Aging (2007) 1.27
Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. Proc Natl Acad Sci U S A (1997) 1.26
Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion (2006) 1.25
Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxid Redox Signal (2011) 1.21
Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis (2011) 1.18
Amyloid-beta-induced mitochondrial dysfunction. J Alzheimers Dis (2007) 1.17
The neurodegenerative mitochondriopathies. J Alzheimers Dis (2009) 1.14
The role of mitochondria in neurodegenerative diseases. J Neurol (2011) 1.05
Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. J Alzheimers Dis (2011) 1.04
Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Longev (2012) 1.03
Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol Dis (2012) 0.93
Bioenergetic medicine. Br J Pharmacol (2014) 0.93
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. Adv Pharmacol (2012) 0.89
Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance. Free Radic Biol Med (2016) 0.82
Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies. Aging Dis (2016) 0.81
PET sheds light on Alzheimer's disease genetic risk. Proc Natl Acad Sci U S A (2007) 0.81
New insights in the amyloid-Beta interaction with mitochondria. J Aging Res (2012) 0.81
Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chain. EMBO J (2003) 0.79
Amyloid precursor protein processing and bioenergetics. Brain Res Bull (2016) 0.78
Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease. J Alzheimers Dis (2016) 0.77
Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds. Oxid Med Cell Longev (2015) 0.77
Aβ oligomers-induced toxicity is attenuated in cells cultured with NbActiv4™ medium. Neurotox Res (2012) 0.77
Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease. J Alzheimers Dis (2016) 0.75
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration. Front Immunol (2017) 0.75
Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol (1989) 3.11
Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology (1997) 2.85
Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol (1996) 2.22
Cytochrome oxidase deficiency in Alzheimer's disease. Neurology (1990) 1.96
Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol (1999) 1.81
Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol (2000) 1.80
Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology (1990) 1.67
A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. N Engl J Med (1989) 1.61
Role of mitochondria in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 1.51
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology (1994) 1.43
Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J Neurosci (1997) 1.36
The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta (1999) 1.23
Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol (2000) 1.20
Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol (1998) 1.09
Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann Neurol (1998) 1.04
Propionate inhibition of succinate:CoA ligase (GDP) and the citric acid cycle in mitochondria. Pediatr Res (1980) 0.97
Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem (2000) 0.96
Friedreich ataxia: III. Mitochondrial malic enzyme deficiency. Neurology (1982) 0.94
Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Res (2001) 0.92
Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particles. Arch Biochem Biophys (1994) 0.92
Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology (1981) 0.90
Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem Biophys Res Commun (1998) 0.90
Human mitochondrial electron transport chain: assay of succinate: cytochrome c reductase in leukocytes, platelets and cultured fibroblasts. Biochem Med (1981) 0.87
Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology (1996) 0.86
Cytochrome oxidase inhibition: a novel animal model of Alzheimer's disease. J Geriatr Psychiatry Neurol (1992) 0.85
Friedreich ataxia. II. Normal kinetics of lipoamide dehydrogenase. Neurology (1979) 0.85
Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Exp Neurol (2001) 0.83
Lipoamide dehydrogenase deficiency with primary lactic acidosis: favorable response to treatment with oral lipoic acid. J Pediatr (1984) 0.82
Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Biochem Biophys Res Commun (1999) 0.82
Friedreich's ataxia: I. Normal pyruvate dehydrogenase complex activity in platelets. Ann Neurol (1978) 0.81
Loosely coupled mitochondrial oxidative phosphorylation induced by protoporphyrin. Biochem Med (1979) 0.81
Protonmotive force in muscle mitochondria. Muscle Nerve (1982) 0.80
Mitochondrial function after asphyxia in newborn lambs. Stroke (1989) 0.79
Mitochondrial DNA-depleted neuroblastoma (Rho degrees) cells exhibit altered calcium signaling. Biochim Biophys Acta (2000) 0.79
Friedreich's disease: IV. Reduced mitochondrial malic enzyme activity in heterozygotes. Neurology (1983) 0.79
Secondary inhibition of 2-ketoglutarate dehydrogenase complex by MPTP. Neuroreport (1998) 0.79
Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions. J Clin Invest (1990) 0.78
Parkinson disease in twins. JAMA (1999) 0.75
Bilirubin increases mitochondrial inner membrane conductance. Biochem Med (1985) 0.75
Urea cycle regulation: I. Coupling of ornithine metabolism to mitochondrial oxidative phosphorylation. Neurology (1980) 0.75
Developmental changes in newborn lamb brain mitochondrial activity and postasphyxial lipid peroxidation. Proc Soc Exp Biol Med (1995) 0.75
Myxothiazol resistance in human mitochondria. Biochim Biophys Acta (1988) 0.75
A mechanism of toxicity of isovaleric acid in rat liver mitochondria. Biochem Med (1982) 0.75
Mitochondrial impact on nerve growth factor production in vascular smooth muscle-derived cells. Biochim Biophys Acta (1999) 0.75